Provided by Tiger Trade Technology Pte. Ltd.

YieldMax MRNA Option Income Strategy ETF

35.77
+2.527.58%
Pre-market: 35.40-0.3700-1.03%04:39 EDT
Volume:266.73K
Turnover:9.17M
Market Cap:145.05M
PE:- -
High:35.77
Open:32.84
Low:32.73
Close:33.25
52wk High:42.39
52wk Low:13.60
Shares:4.05M
Float Shares:4.05M
Volume Ratio:0.98
T/O Rate:6.58%
Dividend:15.23
Dividend Rate:42.59%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Moderna Raised to Outperform from Market Perform by William Blair

Dow Jones
·
Aug 20

Piper Sandler Adjusts Price Target on Moderna to $167 From $77, Maintains Overweight Rating

MT Newswires Live
·
Aug 20

BofA Securities Upgrades Moderna to Neutral From Underperform Following Intismeran 'Success', Raises Price Target to $170 From $40

MT Newswires Live
·
Aug 20

Asia Morning Call-Global Markets

Reuters
·
Aug 20

Top Midday Gainers

MT Newswires Live
·
Aug 20

U.S. Stocks on the MOVE-ServiceNow, Zoom, US Homebuilders

Reuters
·
Aug 20

Moderna upgraded to Neutral from Underperform at BofA

TIPRANKS
·
Aug 20

Short Sellers Lose $4.8 Billion as Moderna Stock (MRNA) Soars 150%

TIPRANKS
·
Aug 20

JPMorgan Weighs In on Moderna Stock Amid 140%-Plus Jump (And It Ain’t Pretty)

TIPRANKS
·
Aug 20

US Equity Indexes Rise as Treasury Yields Ease on Buyback Ramp

MT Newswires Live
·
Aug 20

Moderna $30 Bln Gain Implies Many Cancer Successes

Reuters
·
Aug 20

Midday Market Movers: Moderna, Pilgrims Pride, Target, Gold Miners & More

Deep News
·
Aug 20

Moderna Stock (MRNA) Soars 133%; Five-Star William Blair Analyst Says Strong Cancer Data Could Be a Game-Changer

TIPRANKS
·
Aug 20

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Aug 20

Flash Heard: Why Healthcare is Partying Like It's Late 2020

Dow Jones
·
Aug 20

U.S. Stocks on the MOVE-Marvell, Pilgrim's Pride, ServiceNow

Reuters
·
Aug 19

Top Midday Stories: Treasury Lifts Buyback Cap on Long-Dated Securities; Moderna, Merck Say Melanoma Vaccine Meets Primary Endpoint in Trial

MT Newswires Live
·
Aug 19

Goldman Sachs Adjusts Price Target on Moderna to $120 From $67, Keeps Neutral Rating

MT Newswires Live
·
Aug 19

Why 2026 is Biotech's Comeback Year

Dow Jones
·
Aug 19

Moderna data bode well for Sellas into imminent readout, says Maxim

TIPRANKS
·
Aug 19